Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 40 Colorectal Neoplasms 24 Carcinoma, Non-Small-Cell Lung 18 Rectal Neoplasms 14 Lung Neoplasms 13 Stomach Neoplasms 12 Esophageal Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 9 Esophageal Squamous Cell Carcinoma 9 Prostatic Neoplasms 8 Pancreatic Neoplasms 8 Neoplasm Metastasis 8 Colonic Neoplasms 8 Carcinoma, Hepatocellular 8 Adenocarcinoma Of Esophagus 8 Sarcoma 7 Ovarian Neoplasms 7 Neoplasms 6 Head and Neck Neoplasms 6 Urinary Bladder Neoplasms 5 Osteosarcoma 5 Liver Neoplasms 5 Kidney Neoplasms 4 Inflammatory Breast Neoplasms 4 Fallopian Tube Neoplasms 4 Carcinoma, Renal Cell 4 Breast Neoplasms, Male 4 Turcot syndrome 3 Multiple Myeloma 3 Locally Advanced Rectal Cancer 3

Interventions

blinatumomab 9 Cyclophosphamide 7 Rituximab 6 Lenalidomide 6 Dexamethasone 5 Azacitidine 5 venetoclax 4 fludarabine 4 Cytarabine 4 fludarabine phosphate 3 Maintenance 3 Busulfan 3 tislelizumab 2 thymoglobulin 2 pembrolizumab 2 obinutuzumab 2 daratumumab 2 Whole-Body Irradiation 2 N,N-dicyclohexyl-isoborneol-10-sulfonamide 2 Methotrexate 2 Melphalan 2 Immunotherapy 2 Imatinib Mesylate 2 Drug Therapy 2 Docetaxel 2 Decitabine 2 Clofarabine 2 Cladribine 2 Carboplatin 2 Calcium Dobesilate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasm, Residual × Neoadjuvant Therapy × Clear all

NCT00551577 2007-10-31

PRIMOVAR-1

University Hospital, Bonn

Phase 2 Unknown

Ovarian Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡